<!DOCTYPE html>
<html><head><style>table, th, td {border: 1px solid black;border-collapse: collapse;}</style></head>
<table colsep="0" frame="topbot" id="t0005" trsep="0" xmlns="http://www.elsevier.com/xml/common/cals/dtd">
<label>
        Table 1
       </label>
<caption id="cn0015">
<simple-para id="sp0025" view="all">
         Small-molecules of the cancer API set inhibiting &gt;80% AspH activity.
        </simple-para>
</caption>
<tgroup cols="5">
<colspec align="left" colname="col1"/>
<colspec align="left" colname="col2"/>
<colspec align="left" colname="col3"/>
<colspec align="left" colname="col4"/>
<colspec align="left" colname="col5"/>
<thead>
<tr trsep="1" valign="top">
<td xmlns="http://www.elsevier.com/xml/common/dtd"/>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           Inhibitor
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">

<sup loc="post">
            ,
           </sup>

           AspH inhibition at 20 μM [%]
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">

           IC
           <inf loc="post">
            50
           </inf>
           [μM]
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           Reported biochemical target
          </td>
</tr>
</thead>
<tbody>
<tr valign="top">
<td role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd">
           1
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
<inline-figure baseline="0.0">
<link id="lk00015" locator="fx1" xlink:href="pii:S0968089620305058/fx1" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/>
</inline-figure>
<br/>
           Pyridine-2,4-dicarboxylic acid (2,4-PDCA)
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           100.0 ± 0.6
           
</td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           0.02 ± 0.01
           
</td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           –
          </td>
</tr>
<tr valign="top">
<td role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd">
           2
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
<inline-figure baseline="0.0">
<link id="lk00020" locator="fx2" xlink:href="pii:S0968089620305058/fx2" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/>
</inline-figure>
<br/>
           (
           <italic>
            R
           </italic>
           )-Gossypol (AT-101)
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           101.2 ± 2.3
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           0.25 ± 0.01
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           Broad-spectrum inhibitor of anti-apoptotic Bcl-2 proteins
           <cross-refs id="r0005" refid="b0185 b0190 b0195">
<sup loc="post">
             37-39
            </sup>
</cross-refs>
</td>
</tr>
<tr valign="top">
<td role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd">
           3
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
<inline-figure baseline="0.0">
<link id="lk00025" locator="fx3" xlink:href="pii:S0968089620305058/fx3" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/>
</inline-figure>
<br/>
           Bleomycin A
           <inf loc="post">
            2
           </inf>

<sup loc="post">
            ,
           </sup>

</td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           97.5 ± 1.3
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           1.47 ± 0.42
           
</td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           Antitumor antibiotic promoting DNA-degradation
           <cross-refs id="r0010" refid="b0200 b0205 b0210">
<sup loc="post">
             40–42
            </sup>
</cross-refs>
</td>
</tr>
<tr valign="top">
<td role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd">
           4
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
<inline-figure baseline="0.0">
<link id="lk00030" locator="fx4" xlink:href="pii:S0968089620305058/fx4" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/>
</inline-figure>
<br/>
           Venetoclax (ABT-199)
           
</td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           97.2 ± 0.2
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           1.40 ± 0.14
           
</td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           Selective inhibitor of the anti-apoptotic protein Bcl-2
           <cross-refs id="r0015" refid="b0215 b0220">
<sup loc="post">
             43,44
            </sup>
</cross-refs>
</td>
</tr>
<tr valign="top">
<td role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd">
           5
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
<inline-figure baseline="0.0">
<link id="lk00035" locator="fx5" xlink:href="pii:S0968089620305058/fx5" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/>
</inline-figure>
<br/>
           Belinostat (PXD101)
           
</td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           97.1 ± 0.2
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           7.49 ± 1.26
           
</td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           Broad-spectrum HDAC inhibitor
           
</td>
</tr>
<tr valign="top">
<td role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd">
           6
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
<inline-figure baseline="0.0">
<link id="lk00040" locator="fx6" xlink:href="pii:S0968089620305058/fx6" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/>
</inline-figure>
<br/>
           Midostaurin (PKC412)
           
</td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           91.7 ± 0.9
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           9.43 ± 3.07
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           Inhibitor of activating mutations of the FMS-like tyrosine kinase-3 (FLT3)
           <cross-refs id="r0020" refid="b0230 b0235">
<sup loc="post">
             46,47
            </sup>
</cross-refs>
</td>
</tr>
<tr valign="top">
<td role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd">
           7
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
<inline-figure baseline="0.0">
<link id="lk00045" locator="fx7" xlink:href="pii:S0968089620305058/fx7" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/>
</inline-figure>
<br/>
           Tubacin
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           90.3 ± 3.5
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           4.12 ± 0.50
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           Selective inhibitor of HDAC6
           
</td>
</tr>
<tr valign="top">
<td role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd">
           8
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
<inline-figure baseline="0.0">
<link id="lk00050" locator="fx8" xlink:href="pii:S0968089620305058/fx8" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/>
</inline-figure>
<br/>
           Navitoclax (ABT-263)
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           90.1 ± 0.1
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           1.03 ± 0.12
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           Inhibitor of anti-apoptotic proteins Bcl-2, Bcl-X
           <inf loc="post">
            L
           </inf>
           , and Bcl-w
           
</td>
</tr>
<tr valign="top">
<td role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd">
           9
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
<inline-figure baseline="0.0">
<link id="lk00055" locator="fx9" xlink:href="pii:S0968089620305058/fx9" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/>
</inline-figure>
<br/>
           Mithramycin A
           
</td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           86.9 ± 2.1
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           9.50 ± 0.28
           
</td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           Antitumor antibiotic inhibiting gene transcription
           
</td>
</tr>
<tr valign="top">
<td role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd">
           10
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           Plicamycin
           
</td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           85.4 ± 3.9
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           –
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           –
          </td>
</tr>
<tr valign="top">
<td role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd">
           11
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
<inline-figure baseline="0.0">
<link id="lk00060" locator="fx10" xlink:href="pii:S0968089620305058/fx10" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/>
</inline-figure>
<br/>
           Obatoclax (GX15-070)
           
<sup loc="post">
            ,
           </sup>

</td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           82.0 ± 0.6
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           13.2 ± 3.1
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           Broad-spectrum inhibitor of anti-apoptotic Bcl-2 proteins
           <cross-refs id="r0025" refid="b0255 b0260">
<sup loc="post">
             51,52
            </sup>
</cross-refs>
</td>
</tr>
<tr valign="top">
<td role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd">
           12
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
<inline-figure baseline="0.0">
<link id="lk00065" locator="fx11" xlink:href="pii:S0968089620305058/fx11" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/>
</inline-figure>
<br/>
           Vemurafenib (PLX4032)
           
</td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           81.1 ± 0.5
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           12.9 ± 1.6
           
</td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           Selective inhibitor of mutant (V600E) BRAF kinase
           <cross-refs id="r0030" refid="b0265 b0270">
<sup loc="post">
             53,54
            </sup>
</cross-refs>
</td>
</tr>
<tr valign="top">
<td role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd">
           13
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
<inline-figure baseline="0.0">
<link id="lk00070" locator="fx12" xlink:href="pii:S0968089620305058/fx12" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/>
</inline-figure>
<br/>
           ABT-737
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           –
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           3.38 ± 0.34
          </td>
<td xmlns="http://www.elsevier.com/xml/common/dtd">
           Inhibitor of anti-apoptotic proteins Bcl-2, Bcl-X
           <inf loc="post">
            L
           </inf>
           , and Bcl-w
           
</td>
</tr>
</tbody>
</tgroup>
<table-footnote id="tblfn1">

<note-para id="np005" view="all">
         The complete screening results are shown in the Supporting Data Sheet. AspH inhibition assays (20 μM fixed inhibitor concentration) were of good quality which high signal-to-noise (S/N) and high Z'-factors
         
         (&gt;0.8 for each plate) manifest (
         
         ).
        </note-para>
</table-footnote>
<table-footnote id="tblfn2">

<note-para id="np010" view="all">
         Mean of two independent runs (n = 2; mean ± standard deviation, SD) using 50 nM His
         <inf loc="post">
          6
         </inf>
         -AspH
         <inf loc="post">
          315–758
         </inf>
         , 1 μM hFX-CP
         <inf loc="post">
          101–119
         </inf>
         (
         
         b), 100 μM
         <small-caps>
          l
         </small-caps>
         -ascorbic acid (LAA), 3 μM 2OG, and 2 μM ammonium iron(II) sulfate hexahydrate (FAS, (NH
         <inf loc="post">
          4
         </inf>
         )
         <inf loc="post">
          2
         </inf>
         Fe(SO
         <inf loc="post">
          4
         </inf>
         )
         <inf loc="post">
          2
         </inf>
         ·6H
         <inf loc="post">
          2
         </inf>
         O) in 50 mM HEPES buffer (pH 7.5, 20 °C).
        </note-para>
</table-footnote>
<table-footnote id="tblfn3">

<note-para id="np015" view="all">
         Used as a positive inhibition control (n = 64; mean ± SD).
        </note-para>
</table-footnote>
<table-footnote id="tblfn4">

<note-para id="np020" view="all">
         n = 4; mean ± SD.
        </note-para>
</table-footnote>
<table-footnote id="tblfn5">

<note-para id="np025" view="all">
         Used as the hydrogensulfate salt.
        </note-para>
</table-footnote>
<table-footnote id="tblfn6">

<note-para id="np030" view="all">
         Approved API for clinical use as a human therapeutic.
        </note-para>
</table-footnote>
<table-footnote id="tblfn7">

<note-para id="np035" view="all">
         Hill coefficient
         
         &lt; −2.0.
        </note-para>
</table-footnote>
<table-footnote id="tblfn8">

<note-para id="np040" view="all">
         Mithramycin A and plicamycin are identical.
        </note-para>
</table-footnote>
<table-footnote id="tblfn9">

<note-para id="np045" view="all">
         Used as the methanesulfonate salt.
        </note-para>
</table-footnote>
</table>
</html>
